Anika Therapeutics Raises FY2026 Sales Guidance from $114.000M-$122.500M to $118.460M-$124.101M vs $118.612M Est
Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $114.000 million-$122.500 million to $118.460 million-$124.101 million vs $118.612 million estimate.
Anika Therapeutics raised its prediction for how much money it will make next year—a sign the company expects its business to do better. When a company feels more confident about its future, that can show investors the business is on a healthier track.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.